160 related articles for article (PubMed ID: 36678731)
1. Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy.
Esteruelas G; Souto EB; Espina M; García ML; Świtalska M; Wietrzyk J; Gliszczyńska A; Sánchez-López E
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678731
[TBL] [Abstract][Full Text] [Related]
2. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis.
Öztürk AA; Namlı İ; Güleç K; Kıyan HT
Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668
[TBL] [Abstract][Full Text] [Related]
3. pH-Responsive PLGA Nanoparticle for Controlled Payload Delivery of Diclofenac Sodium.
Khanal S; Adhikari U; Rijal NP; Bhattarai SR; Sankar J; Bhattarai N
J Funct Biomater; 2016 Aug; 7(3):. PubMed ID: 27490577
[TBL] [Abstract][Full Text] [Related]
4. Design and optimization of PLGA-based diclofenac loaded nanoparticles.
Cooper DL; Harirforoosh S
PLoS One; 2014; 9(1):e87326. PubMed ID: 24489896
[TBL] [Abstract][Full Text] [Related]
5. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
6. Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes.
López-Machado A; Díaz N; Cano A; Espina M; Badía J; Baldomà L; Calpena AC; Biancardi M; Souto EB; García ML; Sánchez-López E
Int J Pharm; 2021 Nov; 609():121188. PubMed ID: 34655707
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.
Cetin M; Atila A; Kadioglu Y
AAPS PharmSciTech; 2010 Sep; 11(3):1250-6. PubMed ID: 20697984
[TBL] [Abstract][Full Text] [Related]
8.
Küçüktürkmen B; Öz UC; Bozkir A
Turk J Pharm Sci; 2017 Apr; 14(1):56-64. PubMed ID: 32454595
[TBL] [Abstract][Full Text] [Related]
9. Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics.
Ünal S; Doğan O; Aktaş Y
Beilstein J Nanotechnol; 2022; 13():1393-1407. PubMed ID: 36483636
[TBL] [Abstract][Full Text] [Related]
10. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
11. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment.
Arias JL; López-Viota M; López-Viota J; Delgado AV
Int J Pharm; 2009 Dec; 382(1-2):270-6. PubMed ID: 19712736
[TBL] [Abstract][Full Text] [Related]
12. Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters.
Beck-Broichsitter M; Schmehl T; Gessler T; Seeger W; Kissel T
J Control Release; 2012 Feb; 157(3):469-77. PubMed ID: 21930166
[TBL] [Abstract][Full Text] [Related]
13. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
14. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
15. Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.
Silva-Abreu M; Calpena AC; Espina M; Silva AM; Gimeno A; Egea MA; García ML
Pharm Res; 2018 Jan; 35(1):11. PubMed ID: 29299768
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel intraarticular injection of diclofenac for the treatment of arthritis: a preclinical study in the rabbit model.
Wen X; Huang X; Wu H
Acta Biochim Pol; 2021 Jan; 68(1):71-76. PubMed ID: 33480230
[TBL] [Abstract][Full Text] [Related]
17. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
Mehta AK; Yadav KS; Sawant KK
Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
[TBL] [Abstract][Full Text] [Related]
18. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
Yadav KS; Sawant KK
Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
[TBL] [Abstract][Full Text] [Related]
19. Rhoifolin loaded in PLGA nanoparticles alleviates oxidative stress and inflammation
Al-Shalabi E; Abusulieh S; Hammad AM; Sunoqrot S
Biomater Sci; 2022 Sep; 10(19):5504-5519. PubMed ID: 35920694
[TBL] [Abstract][Full Text] [Related]
20. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
